Related Experiment Video
Updated: Dec 16, 2025
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Controlled drug delivery for alopecia: A review
Shefrin Salim1, Kaladhar Kamalasanan1
1Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi 682 041, Kerala, India.
Abstract:
Alopecia or hair loss is a benign treatable disorder which, over time, becomes chronic, affecting a significant fraction of the population that affects the patient's self-esteem and quality of life. The existing treatment regimen for alopecia is inadequate for drug delivery directly to hair follicles to result in continuous hair growth. The challenges are due to multiple-dose regimes and patient non-adherence, where it requires motivated clinical attention. Developing a prolonged drug delivery system by exploration of specific pathways to advance the delivery system into nanomedicine would be beneficial for clinical advancement. In this review, factors affecting the progress of the current therapeutic regimen towards controlled release nanomedicine (CRNM's) are analysed for existing clinical unmet needs, current treatment strategy, and research efforts taken in this direction. Correspondingly, changes in anatomy and pathophysiology of hair growth being analyzed in detail to focus the exact scenario of hair growth cycle and supplementation of medication. Besides, the current treatment regimen with various classes of drugs, their different pathways, and dosing limitations are analyzed. Possibilities of research effort for prolonged drug delivery are discussed in detail, including marketed products, clinical trials as well as various patents filed in the direction. Repurposing of multiple therapeutics using the nanotechnology platform, subsequently, results in a strategy to develop nanomedicine to treat alopecia, which could develop into several technologies (CRNM's), fore coming years from now.
Related Concept Videos
01:22Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
01:16Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
01:29Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:18Drug Delivery: Enteral Route
01:18Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
01:22Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...